Anticancer agent 64
Anticancer agent 64 (compound 5m) shows cytotoxic activity in CCRF-CEM cells, with IC50 of 2.4 μM. Anticancer agent 64 shows good anticancer activity through apoptosis induction. Anticancer agent 64 induces caspase 3 and 7 activation and PARP cleavage. Anticancer agent 64 induces significant effect of mitochondria depolarization[1].
Product Specifications
CAS Number
2387902-92-1
UNSPSC
12352005
Target
Apoptosis; Bcl-2 Family; Caspase; PARP
Type
Reference compound
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-64.html
Solubility
10 mM in DMSO
Smiles
OC([C@]12[C@@]([C@@H](CC2)C(C)=C)([H])[C@]3([H])[C@@](CC1)([C@]4([C@]([C@@]5([C@@](C(C)(C6=C(SC(N)=N6)C5)C)([H])CC4)C)([H])CC3)C)C)=O
Molecular Formula
C31H46N2O2S
Molecular Weight
510.77
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Bax; Bcl-2; Caspase 3; Caspase 7; PARP
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Actl6a (Actin-like Protein 6A, 53kD BRG1-Associated Factor A, Actin-Related Protein Baf53a, BRG1-Associated Factor 53A, BAF53A, Actl6a, Actl6, Baf53a) (MaxLight 490) discontinued
Anti-CD146/MCAM Antibody Picoband® (monoclonal, 4C12), Cy3 Conjugate
Innovative Grade US Origin Bovine Calf Tendon Deep Digital Flexor Fresh in PBS
Lentiviral human SMYD1 sgRNA gene knockout kit - Lentiviral human SMYD1 sgRNA gene knockout kit (100)